Across the country, people with metal-on-metal hip implants are dealing with terrible pain on a...READ MORE
Baby Powder and Ovarian Cancer: Here’s What You Need to Know
You’ve probably heard about the link between talcum powder and ovarian cancer in recent years. Many talcum powder plaintiffs, eager to advise women to discontinue use of this product, have been outspoken on this issue. This issue has also been in the news as juries in several talcum powder lawsuits have returned verdict for plaintiffs against the pharmaceutical companies and manufacturers of these products. Some plaintiffs have even been awarded millions of dollars in damages, sending a clear message that these companies bear a responsibility to advise consumers of the potential side effects of their products.
Because Jonson & Johnson® failed to warn of the risk of ovarian cancer, several women and their families have been awarded significant monetary awards. These lawsuits are important and could potentially change the way baby powder is packaged and labeled. This leads to two important questions:
- When did pharmaceutical companies and powder manufacturers become aware of the link between perineal application of talc, the main ingredient in their product, and the associated risk of ovarian cancer?
- Why didn’t these companies provide a simple warning on their packaging, which would have allowed consumers to make an informed decision about their use of these products?
Because baby powder absorbs moisture and reduces rashes and chafing, it has long been considered essential in many homes. These attributes made it a frequently used substance on babies during diaper changes and by women for hygienic purposes. Here are a few important facts you need to know about talc-based baby powder and its link to ovarian cancer.
- Ovarian cancer is the fifth most deadly cancer among women
- Talc is a naturally occurring mineral found in personal care products like Johnson & Johnson’s Baby Powder and Shower to Shower
- Cosmetics and body products like baby powder are not required to have FDA approval before they go on the market
- Women over 40 are at greater risk of ovarian cancer
- Women over the age of 63 face the greatest risk
- African American women are more likely to use talc products and therefore have a greater risk of developing talc-caused ovarian cancer